Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Sales

Immunome (IMNM) Return on Assets (2023 - 2025)

Historic Return on Assets for Immunome (IMNM) over the last 3 years, with Q3 2025 value amounting to 0.79%.

  • Immunome's Return on Assets rose 3600.0% to 0.79% in Q3 2025 from the same period last year, while for Sep 2025 it was 0.79%, marking a year-over-year increase of 3600.0%. This contributed to the annual value of 1.57% for FY2024, which is N/A changed from last year.
  • Immunome's Return on Assets amounted to 0.79% in Q3 2025, which was up 3600.0% from 0.7% recorded in Q2 2025.
  • In the past 5 years, Immunome's Return on Assets ranged from a high of 0.7% in Q2 2025 and a low of 1.23% during Q4 2024
  • Its 3-year average for Return on Assets is 0.93%, with a median of 0.89% in 2023.
  • As far as peak fluctuations go, Immunome's Return on Assets plummeted by -3200bps in 2024, and later skyrocketed by 3600bps in 2025.
  • Immunome's Return on Assets (Quarter) stood at 0.91% in 2023, then tumbled by -36bps to 1.23% in 2024, then surged by 36bps to 0.79% in 2025.
  • Its Return on Assets was 0.79% in Q3 2025, compared to 0.7% in Q2 2025 and 0.75% in Q1 2025.